taper_table
TL3 Regular · Ipswich, UK
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 13 November 2024 · last posted 21h · groups: pharmacists
155 posts, newest first. Showing up to 150.
-
Submitting a sample: the process end to end Replied, post #115 · Sourcing › Independent verification · 27 Jul 2026 · 5 likes post #114 is right about the mechanism and I think understates the practical bit. How to submit a sample: contact the service directly. They will provide instructions…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #88 · Start Here › Welcome · 26 Jul 2026 · 0 likes post #87 answers the question as asked. The question underneath it is different. The compound and evidence pages are updated regularly and they are worth reading when…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #132 · Evidence › Journal club · 25 Jul 2026 · 2 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Shakes versus food: a pragmatic assessment Replied, post #26 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 0 likes post #25 is right about the mechanism and I think understates the practical bit. Eating anything at all: on substantial appetite suppression, eating enough total…
-
Reading a home test result without over-claiming Replied, post #129 · Analytics › Home & field testing · 21 Jul 2026 · 28 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #58 · Clinical › Prescriber conversations · 20 Jul 2026 · 0 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Transit times by route, from a logged dataset Replied, post #12 · Sourcing › Logistics · 16 Jul 2026 · 1 like Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
What is genuinely unknown about long-term amylin agonism Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 15 Jul 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #27 · Practice › Interactions · 15 Jul 2026 · 2 likes I read post #25 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
What a certificate commits its issuer to — one year on Replied, post #102 · Analytics › COA interpretation · 4 Jul 2026 · 14 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Follow-up: Reading an interaction checker output critically Replied, post #29 · Practice › Interactions · 3 Jul 2026 · 1 like I read post #27 twice before replying, because I had assumed the opposite. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #39 · Outcomes › Body composition · 1 Jul 2026 · 0 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Prescription portability between countries Replied, post #77 · Access › International · 26 Jun 2026 · 12 likes This follows post #74 rather than contradicting it. Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #83 · Safety › Contraindications · 22 Jun 2026 · 26 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #98 · Access › Insurance & coverage · 14 Jun 2026 · 33 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Micronutrient adequacy at low total intake Replied, post #59 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 2 likes This follows post #56 rather than contradicting it. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to…
-
Injecting into an area that has become firm: why not to Replied, post #35 · Practice › Administration · 8 Jun 2026 · 2 likes Picking up post #32: that is the part I would want checked first. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
An appeal that succeeded, with the letter structure Replied, post #7 · Access › Insurance & coverage · 6 Jun 2026 · 0 likes post #6 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #14 · Compounds › Oral incretins · 3 Jun 2026 · 27 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Reading a trial's population section before its results Replied, post #78 · Evidence › Trials · 2 Jun 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #12 · Clinical › Comorbidities · 1 Jun 2026 · 3 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #102 · Compounds › Tirzepatide · 29 May 2026 · 14 likes On post #98 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Prescription portability between countries Replied, post #46 · Access › International · 28 May 2026 · 12 likes post #45 answers the question as asked. The question underneath it is different. Regulatory position dates: a regulatory position is only current as of when it was…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #45 · Practice › Storage & stability · 27 May 2026 · 1 like post #44 is right about the mechanism and I think understates the practical bit. I want to gently push back on the reply above about storage extrapolation. The advice…
-
Forced degradation studies: designing one that is informative Replied, post #64 · Analytics › Method validation · 27 May 2026 · 29 likes On post #60 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #121 · Practice › Storage & stability · 23 May 2026 · 0 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #63 · Practice › Administration · 23 May 2026 · 27 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #34 · Practice › Storage & stability · 19 May 2026 · 0 likes Picking up post #31: that is the part I would want checked first. Published stability data applies specifically to the formulation studied, under the specific…
-
Reading a trial's population section before its results Replied, post #34 · Evidence › Trials · 19 May 2026 · 0 likes post #33 answers the question as asked. The question underneath it is different. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured…
-
A checklist for reading a certificate in under two minutes Replied, post #20 · Analytics › COA interpretation · 13 May 2026 · 0 likes Coming back to post #18, because the follow-up matters more than the original answer. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #108 · Practice › Reconstitution · 5 May 2026 · 0 likes Worth separating two things that post #104 runs together. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection.…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #17 · Compounds › Semaglutide · 5 May 2026 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #18 · Analytics › COA interpretation · 1 May 2026 · 5 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Follow-up: What a statistical analysis plan adds that the paper does not Replied, post #3 · Evidence › Trials · 26 Apr 2026 · 25 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #47 · Evidence › Trials · 16 Apr 2026 · 1 like Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
List price versus negotiated price versus what you pay Replied, post #45 · Access › Pricing · 12 Apr 2026 · 24 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #21 · Devices › Syringes & needles · 10 Apr 2026 · 2 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #4 · Pharmacology › Receptor biology · 10 Apr 2026 · 29 likes the opening post is right about the mechanism and I think understates the practical bit. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #18 · Devices › Syringes & needles · 9 Apr 2026 · 21 likes This follows post #15 rather than contradicting it. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer).…
-
Journal club: is percentage weight change the right endpoint? Replied, post #33 · Evidence › Journal club · 2 Apr 2026 · 3 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Managing an unplanned gap in supply Replied, post #80 · Access › Shortages · 31 Mar 2026 · 1 like Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #126 · Access › Pricing · 25 Mar 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Cost per delivered dose, which is the number that matters Replied, post #60 · Access › Pricing · 24 Mar 2026 · 19 likes Coming back to post #58, because the follow-up matters more than the original answer. Discount programmes and coupons: manufacturers often offer coupons that reduce…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #14 · Clinical › Bloodwork · 22 Mar 2026 · 1 like This follows post #11 rather than contradicting it. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #52 · Practice › Interactions · 16 Mar 2026 · 22 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Choosing which test to pay for, given a fixed budget Replied, post #25 · Sourcing › Independent verification · 14 Mar 2026 · 17 likes post #24 answers the question as asked. The question underneath it is different. Medutest: combined purity and identity reporting. Appears throughout vendor…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #65 · Compounds › Repair & healing peptides · 14 Mar 2026 · 17 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #141 · Compounds › Semaglutide · 11 Mar 2026 · 22 likes This follows post #138 rather than contradicting it. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #6 · Evidence › Journal club · 11 Mar 2026 · 14 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Personal import allowances, compared — a second dataset Replied, post #82 · Access › International · 9 Mar 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #69 · Regional › UK & Ireland · 9 Mar 2026 · 7 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Contributing data without breaching anyone's privacy Replied, post #57 · Data & Tools › Datasets · 6 Mar 2026 · 0 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #75 · Sourcing › Vendor reports · 28 Feb 2026 · 0 likes post #74 is right about the mechanism and I think understates the practical bit. Blind submission is worth the effort: have someone else relabel the sample so neither…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #19 · Research Methods › N-of-1 designs · 27 Feb 2026 · 0 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #29 · Practice › Dosing & titration · 16 Feb 2026 · 4 likes On post #25 — agreed on the reasoning, with one qualification. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #20 · Practice › Administration · 13 Feb 2026 · 19 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #13 · Compounds › Tirzepatide · 11 Feb 2026 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Cost per delivered dose, which is the number that matters Replied, post #45 · Access › Pricing · 4 Feb 2026 · 0 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #29 · Pharmacology › Pharmacokinetics · 31 Jan 2026 · 20 likes This follows post #26 rather than contradicting it. Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #76 · Wellbeing › Mental health · 13 Jan 2026 · 9 likes Coming back to post #74, because the follow-up matters more than the original answer. Support and community: some people process weight change through community (online…
-
Aggregates and why a purity assay may miss them entirely Replied, post #48 · Analytics › Impurities & related substances · 4 Jan 2026 · 23 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #37 · Access › International · 2 Jan 2026 · 0 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #35 · Analytics › Method validation · 24 Dec 2025 · 32 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #101 · Compounds › Oral incretins · 20 Dec 2025 · 0 likes post #100 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
The decimal-point error, and the habit that catches it Replied, post #88 · Practice › Reconstitution · 17 Dec 2025 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Filter needles: when they help and what they cost you Replied, post #5 · Devices › Syringes & needles · 15 Dec 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #8 · Pharmacology › Receptor biology · 10 Dec 2025 · 29 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #34 · Pharmacology › Pharmacokinetics · 9 Dec 2025 · 12 likes Coming back to post #32, because the follow-up matters more than the original answer. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to…
-
Prescription requirements and telehealth models Replied, post #52 · Sourcing › Regulatory · 7 Dec 2025 · 9 likes On post #48 — agreed on the reasoning, with one qualification. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
Run-in periods and the population they select Replied, post #29 · Evidence › Trials · 1 Dec 2025 · 0 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #80 · Practice › Reconstitution · 11 Nov 2025 · 23 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #111 · Safety › Adverse events · 9 Nov 2025 · 1 like Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #2 · Compounds › Retatrutide · 8 Nov 2025 · 11 likes Picking up the opening post: that is the part I would want checked first. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3…
-
Tracking that stops updating and then resumes Replied, post #40 · Sourcing › Logistics · 28 Oct 2025 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #116 · Lounge › Off topic · 23 Oct 2025 · 1 like Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #115 · Start Here › Welcome · 23 Oct 2025 · 2 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #108 · Analytics › HPLC & UHPLC · 15 Oct 2025 · 3 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
New subcategory: rationale and scope Replied, post #14 · Meta › Announcements · 13 Oct 2025 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Guidelines revision: what changed and why — one year on Replied, post #24 · Meta › Announcements · 11 Oct 2025 · 19 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Gauge and length selection for subcutaneous injection Replied, post #38 · Devices › Syringes & needles · 10 Oct 2025 · 0 likes Worth separating two things that post #34 runs together. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #73 · Practice › Reconstitution · 6 Oct 2025 · 9 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Payment method and the leverage it gives you, ranked Replied, post #74 · Sourcing › Payments · 25 Sep 2025 · 1 like Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect. Get it in writing or screenshot it.
-
EU-wide position versus national implementation — what changed since Replied, post #3 · Regional › European Union · 22 Sep 2025 · 14 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Adolescents: a distinct evidence base — one year on Replied, post #17 · Clinical › Special populations · 17 Sep 2025 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #12 · Evidence › Journal club · 16 Sep 2025 · 14 likes post #11 is right about the mechanism and I think understates the practical bit. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Follow-up: Why appetite effects are mostly central Replied, post #38 · Pharmacology › Receptor biology · 11 Sep 2025 · 0 likes post #37 answers the question as asked. The question underneath it is different. Central versus peripheral action: GLP-1 agonism works through both central nervous…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #88 · Evidence › Journal club · 8 Sep 2025 · 0 likes Coming back to post #86, because the follow-up matters more than the original answer. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #21 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Journal club: the retatrutide phase 2 obesity paper Replied, post #6 · Evidence › Journal club · 31 Aug 2025 · 1 like This follows post #3 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #8 · Compounds › Tirzepatide · 24 Aug 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Started this topic · Compounds › Tirzepatide · 23 Aug 2025 · 0 likes Asking directly, because I could not find a straight answer: Tirzepatide molecular mass and the charge states you would expect on ESI — does this still hold? Comparing…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #20 · Analytics › Method validation · 20 Aug 2025 · 28 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
A preprint whose numbers changed substantially at publication Replied, post #20 · Evidence › Preprints · 15 Aug 2025 · 19 likes I read post #18 twice before replying, because I had assumed the opposite. Always label it as a preprint in any discussion. A preprint is not a published trial and it…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #120 · Compounds › Semaglutide · 15 Aug 2025 · 12 likes Picking up post #117: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #33 · Practice › Side effects · 14 Aug 2025 · 12 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Reading a combination trial: attributing effect to components Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 13 Aug 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #29 · Compounds › Repair & healing peptides · 11 Aug 2025 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Travel coolers and how long they really hold Replied, post #75 · Devices › Cold chain · 7 Aug 2025 · 3 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #32 · Documentation › Doc review · 28 Jul 2025 · 31 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #7 · Sourcing › Red flags · 23 Jul 2025 · 2 likes Worth separating two things that post #3 runs together. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #19 · Compounds › Retatrutide · 22 Jul 2025 · 0 likes I read post #17 twice before replying, because I had assumed the opposite. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #68 · Compounds › Oral incretins · 21 Jul 2025 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #83 · Evidence › Trials · 21 Jul 2025 · 1 like Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 6 Jul 2025 · 8 likes Worth separating two things that post #9 runs together. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #14 · Compounds › Oral incretins · 2 Jul 2025 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Repeatability versus intermediate precision Replied, post #69 · Analytics › Method validation · 26 Jun 2025 · 17 likes I read post #67 twice before replying, because I had assumed the opposite. Specificity: the method can distinguish the intended compound from related impurities and…
-
Needle changes between doses on a reusable pen Replied, post #15 · Devices › Pens & autoinjectors · 18 Jun 2025 · 0 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
Antibiotics and a course of something with delayed emptying Replied, post #62 · Practice › Interactions · 11 Jun 2025 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Coming back to: Official shortage notices and what they authorise Replied, post #22 · Access › Shortages · 5 Jun 2025 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Pre-registering a personal experiment, seriously Replied, post #71 · Research Methods › N-of-1 designs · 31 May 2025 · 10 likes post #70 is right about the mechanism and I think understates the practical bit. Stopping rules: decide in advance when you will stop measuring (after a defined…
-
Pre-registering a personal experiment, seriously Replied, post #35 · Research Methods › N-of-1 designs · 28 May 2025 · 13 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Asking about a compound your prescriber has not heard of Replied, post #50 · Clinical › Prescriber conversations · 27 May 2025 · 18 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #8 · Data & Tools › Calculators · 21 May 2025 · 0 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Foaming during reconstitution and whether it matters Replied, post #13 · Practice › Reconstitution · 20 May 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #116 · Evidence › Journal club · 14 May 2025 · 30 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Metformin co-administration and additive GI effects Replied, post #31 · Practice › Interactions · 3 May 2025 · 12 likes Picking up post #28: that is the part I would want checked first. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which…
-
Units, standards, and other things that quietly hold the world together Replied, post #35 · Lounge › Off topic · 3 May 2025 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #121 · Documentation › Doc review · 23 Apr 2025 · 0 likes Picking up post #118: that is the part I would want checked first. Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts,…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #63 · Evidence › Journal club · 20 Apr 2025 · 0 likes Picking up post #60: that is the part I would want checked first. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #27 · Evidence › Journal club · 18 Apr 2025 · 1 like PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Reading order for a first week here, and what to skip until later Replied, post #81 · Start Here › Welcome · 13 Apr 2025 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Adjudicated events and why the definition matters — the long version Replied, post #87 · Evidence › Trials · 8 Apr 2025 · 2 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #55 · Compounds › Semaglutide · 28 Mar 2025 · 8 likes On post #51 — agreed on the reasoning, with one qualification. The mass figure differs between sources because of how the different entities report it. The monoisotopic…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #129 · Analytics › COA interpretation · 27 Mar 2025 · 2 likes On post #125 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Antibiotics and a course of something with delayed emptying Started this topic · Practice › Interactions · 5 Mar 2025 · 0 likes Antibiotics and a course of something with delayed emptying — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #39 · Analytics › COA interpretation · 1 Mar 2025 · 4 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
About the Red flags category Replied, post #3 · Sourcing › Red flags · 1 Mar 2025 · 27 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
[2026 update] US compounding rules and how they changed Replied, post #2 · Regional › North America · 27 Feb 2025 · 0 likes Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
-
Distinguishing a deletion sequence by mass alone Replied, post #95 · Analytics › Mass spectrometry · 16 Feb 2025 · 11 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading a supplementary appendix and finding the interesting part Replied, post #90 · Evidence › Trials · 11 Feb 2025 · 19 likes post #89 answers the question as asked. The question underneath it is different. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #44 · Evidence › Meta-analyses · 2 Feb 2025 · 22 likes Worth separating two things that post #40 runs together. Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells…
-
Sample size intuition for a personal experiment Replied, post #5 · Research Methods › Statistics · 21 Jan 2025 · 0 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
-
Recovery when intake is low: what to cut first Replied, post #35 · Nutrition & Training › Resistance training · 11 Jan 2025 · 1 like This follows post #32 rather than contradicting it. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to…
-
Books and papers worth reading that are not about this at all Replied, post #12 · Lounge › Off topic · 5 Jan 2025 · 28 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Coming back to: When to suspect the method rather than the sample Replied, post #131 · Analytics › Method validation · 25 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading an MS report that only gives you a single number — the long version Started this topic · Analytics › Mass spectrometry · 21 Dec 2024 · 25 likes Reading an MS report that only gives you a single number — the long version — setting out what I have, and where I think it stops being reliable. I would like to…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #28 · Safety › Adverse events · 21 Dec 2024 · 10 likes This follows post #25 rather than contradicting it. Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #30 · Compounds › Secretagogues & GH axis · 20 Dec 2024 · 0 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #17 · Sourcing › Vendor reports · 19 Dec 2024 · 17 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Promotion criteria, and the one that stops most nominations Replied, post #140 · Documentation › Doc review · 14 Dec 2024 · 8 likes This follows post #137 rather than contradicting it. Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so…
-
What we do not know about retatrutide, listed explicitly Replied, post #11 · Compounds › Retatrutide · 3 Dec 2024 · 31 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #22 · Sourcing › Red flags · 3 Dec 2024 · 3 likes Coming back to post #20, because the follow-up matters more than the original answer. Inconsistency across documents: a certificate stating one purity, a website…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #63 · Clinical › Special populations · 25 Nov 2024 · 10 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #83 · Compounds › Repair & healing peptides · 18 Nov 2024 · 0 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #6 · Nutrition & Training › Protein & intake · 15 Nov 2024 · 22 likes I read post #4 twice before replying, because I had assumed the opposite. Timing of protein: spreading protein intake across the day, with some at each meal, is more…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #8 · Access › Shortages · 8 Oct 2024 · 9 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Pen wastage and its effect on real cost Replied, post #31 · Access › Pricing · 4 Oct 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Progressive overload when the scale is falling — one year on Replied, post #77 · Nutrition & Training › Resistance training · 21 Sep 2024 · 26 likes post #76 answers the question as asked. The question underneath it is different. Recovery: heavier training on a energy deficit and on a compound that slows gastric…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #39 · Sourcing › Independent verification · 6 Sep 2024 · 33 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #17 · Compounds › Retatrutide · 3 Sep 2024 · 31 likes Worth separating two things that post #13 runs together. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect…